Chemical libraries towards protein kinase inhibitors

被引:0
|
作者
Kimmich, RDA [1 ]
Park, WKC [1 ]
机构
[1] Ferring Res Inst Inc, San Diego, CA 92121 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Over 500 human protein kinases identified to date are susceptible to play crucial roles in the regulation of many signal transduction pathways, making them significant drug discovery targets. However, their active sites share a high level of similarity, which constitutes a major challenge in the finding of selective and safe inhibitors. In order to meet this challenge, whether via traditional or alternative approaches, the use of chemical libraries to find either unknown natural ligands or specific inhibitors of particular kinases is more important than ever. This review briefly summarizes the recent literature on such libraries of peptides, natural product analogues, and small molecules. Significant chemical scaffolds, some synthetic routes particularly on solid-phase support, and computational tools employed for the efficient design of both selective and bioavailable inhibitors are highlighted.
引用
收藏
页码:661 / 672
页数:12
相关论文
共 50 条
  • [31] Aurora kinase inhibitors: Progress towards the clinic
    Madhu Kollareddy
    Daniella Zheleva
    Petr Dzubak
    Pathik Subhashchandra Brahmkshatriya
    Martin Lepsik
    Marian Hajduch
    Investigational New Drugs, 2012, 30 : 2411 - 2432
  • [32] Aurora kinase inhibitors: Progress towards the clinic
    Kollareddy, Madhu
    Zheleva, Daniella
    Dzubak, Petr
    Brahmkshatriya, Pathik Subhashchandra
    Lepsik, Martin
    Hajduch, Marian
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2411 - 2432
  • [33] Non-kinase targets of protein kinase inhibitors
    Munoz, Lenka
    NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (06) : 424 - U156
  • [34] Non-kinase targets of protein kinase inhibitors
    Lenka Munoz
    Nature Reviews Drug Discovery, 2017, 16 : 424 - 440
  • [35] Chemical inhibitors of protein kinases
    Bridges, AJ
    CHEMICAL REVIEWS, 2001, 101 (08) : 2541 - 2571
  • [36] Pharmacology and pharmacovigilance of protein kinase inhibitors
    Khouri, Charles
    Mahe, Julien
    Caquelin, Laura
    Locher, Clara
    Despas, Fabien
    THERAPIE, 2022, 77 (02): : 207 - 217
  • [37] Protein kinase C inhibitors.
    Swannie H.C.
    Kaye S.B.
    Current Oncology Reports, 2002, 4 (1) : 37 - 46
  • [38] Design strategies for protein kinase inhibitors
    Parang, K
    Sung, GQ
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2004, 7 (05) : 617 - 629
  • [39] Protein kinase inhibitors as antileukemic agents
    Fabbro, D
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2003, 8 (2A) : 526 - 526
  • [40] INHIBITORS OF PROTEIN-KINASE-C
    GORDGE, PC
    RYVES, WJ
    CELLULAR SIGNALLING, 1994, 6 (08) : 871 - 882